{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:48:44Z","timestamp":1787885324865,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001405","name":"Tata Institute of Fundamental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejphar.2020.173430","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T10:42:50Z","timestamp":1596451370000},"page":"173430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2"],"prefix":"10.1016","volume":"886","author":[{"given":"Rujuta R.","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita Pandey","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Nyayanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Modak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173430_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by Chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejphar.2020.173430_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2020.173430_bib3","series-title":"Encyclopedia of Herbs and Their Uses","author":"Bown","year":"1995"},{"key":"10.1016\/j.ejphar.2020.173430_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173430_bib5","series-title":"Possible Drug Candidates for COVID-19 Possible Drug Candidates for COVID-19. ChemRxiv","author":"Chauhan","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib6","series-title":"In Silico Oncology Drug Repositioning and Polypharmacology","author":"Cheng","year":"2019"},{"key":"10.1016\/j.ejphar.2020.173430_bib7","first-page":"682","article-title":"Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era","volume":"18","author":"Cheng","year":"2017","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ejphar.2020.173430_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2016.09.006","article-title":"Drug Repurposing\u00a0: new treatments for Zika virus Infection\u00a0?","author":"Cheng","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173430_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002059","article-title":"Crystal structure and functional analysis of the SARS- Nsp16 complex","volume":"7","author":"Decroly","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2020.173430_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173430_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-0029-1240604","article-title":"Comparative antioxidant, prooxidant and cytotoxic activity of Sigmoidin A and Eriodictyol","volume":"76","author":"Habtemariam","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.ejphar.2020.173430_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2006.01.029","article-title":"Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor","author":"Han","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2020.173430_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2011.572905","article-title":"Ritonavir-boosted protease inhibitors in HIV therapy","volume":"43","author":"Hull","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2020.173430_bib14","first-page":"1","article-title":"A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase Nsp13 in the unwinding of duplex RNA","author":"Jang","year":"2020","journal-title":"Nat. Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173430_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0372-4","article-title":"A novel coronavirus ( 2019-nCoV) causing pneumonia-associated respiratory syndrome","author":"Jiang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2020.173430_bib16","first-page":"488","article-title":"Pemirolast, a new oral nonbronchodilator drug for chronic asthma","volume":"68","author":"Kemp","year":"1992","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.ejphar.2020.173430_bib17","author":"Khaerunnisa"},{"key":"10.1016\/j.ejphar.2020.173430_bib46","series-title":"Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2","author":"Kim","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib18","first-page":"241","article-title":"Chloroquine and Hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","author":"Kumar","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.ejphar.2020.173430_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jmii.2020.02.012","article-title":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths","volume":"53","author":"Lai","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ejphar.2020.173430_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12272-011-0418-3","article-title":"Anti-inflammatory effects of Eriodictyol in lipopolysaccharide- stimulated raw 264.7 murine macrophages","volume":"34","author":"Lee","year":"2011","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2020.173430_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.ejphar.2020.173430_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Lett. Nat."},{"key":"10.1016\/j.ejphar.2020.173430_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejphar.2020.173430_bib47","series-title":"1.95 Angstrom Resolution Crystal Structure of NSP10-NSP16 Complex from SARS-CoV-2","author":"Minasov","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib45","series-title":"SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease COVID-19)","author":"Owen","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bcp.2010.11.004","article-title":"Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity","volume":"81","author":"Rossato","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173430_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs","volume":"15","author":"Salata","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejphar.2020.173430_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173430_bib27","series-title":"Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases","first-page":"293","article-title":"Chapter 18 - Role of Flavonoids in Management of Inflammatory Disorders","author":"Shukla","year":"2019"},{"key":"10.1016\/j.ejphar.2020.173430_bib28","series-title":"Repurposing Therapeutics for COVID-19\u00a0: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface","author":"Smith","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib49","series-title":"The crystal structure of Nsp9 RNA binding protein of SARS CoV-2","author":"Tan","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0\u00a0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2020.173430_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading Oleg Public Access","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2020.173430_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn 2 + inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"Velthuis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2020.173430_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2020.173430_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173430_bib34","article-title":"Remdesivir and Chloroquine effectively inhibit the recently emerged novel coronavirus ( 2019-nCoV) in vitro","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2020.173430_bib35","article-title":"Coronavirus Nsp10\/Nsp16 methyltransferase can be targeted by Nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis","volume":"232","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173430_bib36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5 . 0\u00a0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2020.173430_bib44","article-title":"Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173430_bib37","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2020.173430_bib38","series-title":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation","author":"Xu","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0109180","article-title":"Chloroquine is a zinc ionophore","volume":"9","author":"Xue","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173430_bib48","series-title":"ACE2\u2013B0AT1 complex","author":"Yan","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173430_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a -ketoamide inhibitors","volume":"412","author":"Zhang","year":"2020","journal-title":"Science (80-.)"},{"key":"10.1016\/j.ejphar.2020.173430_bib41","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1021\/jf300601z","article-title":"Effect of Eriodictyol on glucose uptake and insulin resistance in vitro","volume":"60","author":"Zhang","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2020.173430_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejphar.2020.173430_bib43","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3892\/etm.2015.2827","article-title":"Eriodictyol , a plant flavonoid , attenuates LPS - induced acute lung injury through its antioxidative and anti - inflammatory activity","volume":"10","author":"Zhu","year":"2015","journal-title":"Exp. Ther. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:38:28Z","timestamp":1757975908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920305227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":49,"alternative-id":["S0014299920305227"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173430","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173430"}}